Joint Corp
Research Joint Corp (JYNT) on Bullrun: valuation model: 21.3% overvalued, market cap USD 118.75M, P/E 37.7. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerJYNT
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Care Facilities
- CurrencyUSD
- Valuation signal21.3% overvalued
- Market capUSD 118.75M
- P/E37.7
- Financial periodFY2025
- RevenueUSD 54.90M
- Revenue growth5.2%
- Net incomeUSD 2.91M
- Free cash flowUSD 334.72K
- Gross margin79.6%
Valuation Snapshot
Bullrun's latest valuation model marks Joint Corp as 21.3% overvalued; latest market cap is USD 118.75M; P/E is 37.7.
About Joint Corp
The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States. The company provides services under the franchise agreement, including training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. It operates through a network of franchised clinics, offering routine and affordable chiropractic adjustments using a private pay, non-insurance, cash-based model.
Frequently asked questions
Is Joint Corp overvalued or undervalued?
Bullrun's valuation model currently marks Joint Corp as 21.3% overvalued.
What is Joint Corp's market cap?
Joint Corp's market capitalization is USD 118.75M.
What is Joint Corp's P/E ratio?
Joint Corp's price-to-earnings (P/E) ratio is 37.7.
What does Joint Corp do?
The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States. The company provides services under the franchise agreement, including training of franchisees and staff, site selection, construction/vendor management and ongoing operations support.